Candesartan cilexetil/hydrochlorothiazide combination treatment versus high-dose candesartan cilexetil monotherapy in patients with mild to moderate cardiovascular risk (CHILI Triple T)

Gerd Bönner1, Bernhard Landers2, Peter Bramlage31Park-Klinikum Bad Krozingen, Germany; 2Internal Medicine Practice, Diabetes Center, Mayen, Germany; 3Institute for Cardiovascular Pharmacology and Epidemiology, Mahlow, GermanyBackground: Candesartan cilexetil has been shown to effectively reduce...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Bramlage P, Bonner G, Landers B
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Dove Medical Press 2011-02-01
coleção:	Vascular Health and Risk Management
Assuntos:	essential hypertension combination therapy high dose monotherapy candesartan cilexetil non-interventional study diuretics phase IV
Acesso em linha:	https://www.dovepress.com/candesartan-cilexetilhydrochlorothiazide-combination-treatment-versus--peer-reviewed-article-VHRM
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!